Videos

Driving drug development: Exploring the intersection of academe and industry

Length: 0:00 mins | Uploaded 2 days ago | 6 consolidated views

Drug development is an expensive and risky business. Increasingly, biotech and pharma are turning to academe to feed their research pipelines. Can these disparate cultures co-exist and yield real breakthroughs? Following a 2010 MaRS Future of Medicine symposium, we asked academic and industrial scientists — including a 1998 Nobel Laureate — to weigh in on the potential and challenges at the intersection of academia and industry.

MaRS – Building Canada’s next generation of global technology companies. marsdd.com

Related Videos

 

Driving drug development: Exploring the intersection of academe and industry
Length: 9:17 minutes.

International Symposium on Nitric Oxide – John Wallace
Length: 4:1 minutes.

International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters
Length: 0:0 minutes.

Lived it Lecture with David Young – Entrepreneurship 101 2010/11
Length: 57:27 minutes.

MaRS Future of Medicine™ Conference 2010 – Mark Lievonen, Sanofi Pasteur Ltd.
Length: 3:46 minutes.

Dx2010 Markers to Market: Patrice Sarrazin
Length: 2:56 minutes.

Tags: biotechnology, collaboration, drug development, events, health care, innovation, life sciences, nox2010, open source